A Centers for Disease Control and Prevention advisory group has unanimously backed the full approval of the Pfizer/BioNTech coronavirus vaccine for Americans 16 and older.
The CDC’s Advisory Committee on Immunization Practice made the endorsement Monday, one week after the Food and Drug Administration gave the Pfizer vaccine its full approval.
The CDC estimates 209 million Pfizer shots have been administered since the two-dose vaccine was put into circulation in December, CNBC reported.
The Pfizer shot still only has an emergency-use authorization for children ages 12 to 15 and Dr. Peter Marks, the top FDA regulator, said last week his agency would move as “swiftly” as possible to approve shots for children younger than 12 once the company submits more data, CNBC reported.
